Variability in the recommendations for the clinical management of osteoporosis;Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis

Medicina Clinica

Volumn 142, Issue 1, 2014, Pages 15-22

  Sanfélix Genovés, José ^a,b,c   Catalá López, Ferrán ^a,d   Sanfélix Gimeno, Gabriel ^a   Hurtado, Isabel ^a   Baixauli, Cristóbal ^a   Peiró, Salvador ^a  

^a Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana   (Spain)

^b Research Network on Health Services in Chronic Diseases   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d División de Farmacoepidemiología y Farmacovigilancia Agencia Española de Medicamentos y Productos Sanitarios AEMPS   (Spain)

Author keywords

Clinical evidence; Clinical practice guidelines; Osteoporosis; Review; Variability

Indexed keywords

ARTICLE; BONE DENSITOMETRY; DENSITOMETRY; DRUG RESPONSE; HIP FRACTURE; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; PUBLIC HEALTH; RISK FACTOR; SECONDARY PREVENTION; SPINE FRACTURE;

CLINICAL EVIDENCE; CLINICAL PRACTICE GUIDELINES; EVIDENCIA CLÍNICA; GUÍAS DE PRÁCTICA CLÍNICA; OSTEOPOROSIS; REVIEW; REVISIÓN; VARIABILIDAD; VARIABILITY;

FEMALE; HUMANS; MALE; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84891586082     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2012.10.025     Document Type: Article

References (30)

1. O. Johnell, and J.A. Kanis An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos Int 17 2006 1726 1733
2. B. González López-Valcárcel, and M. Sosa Henríquez Estimación del riesgo de fractura osteoporótica a los 10 años para la población española Med Clin (Barc) 2012 10.1016/j.medcli.2011.11.030
3. D. Roig Vilaseca, and C. Gómez Vaquero ¿Qué guía clínica debemos utilizar para el tratamiento de la osteoporosis? Med Clin (Barc) 136 2011 293 294
4. A. Naranjo, S. Ojeda-Bruno, F. Francisco-Hernández, C. Erausquin, I. Rúa-Figueroa, and C. Rodríguez-Lozano Aplicación de las guías de prevención secundaria de fractura osteoporótica y del índice FRAX en una cohorte de pacientes con fractura por fragilidad Med Clin (Barc) 136 2011 290 292
5. R.N. Shiffman, P. Shekelle, J.M. Overhage, J. Slutsky, J. Grimshaw, and A.M. Deshpande Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization Ann Intern Med 139 2003 493 498
6. R. Grol, F.A. Cluzeau, and J.S. Burgers Clinical practice guidelines: Towards better quality guidelines and increased international collaboration Br J Cancer 89 Suppl 1 2003 S4 S8
7. A. Cranney, L. Waldegger, I.D. Graham, M. Man-Son-Hing, A. Byszewski, and D.S. Ooi Systematic assessment of the quality of osteoporosis guidelines BMC Musculoskelet Disord 3 2002 20
8. E.M. Lewiecki Review of guidelines for bone mineral density testing and treatment of osteoporosis Curr Osteoporos Rep 3 2005 75 83
9. C.A. Morris, D. Cabral, H. Cheng, J.N. Katz, J.S. Finkelstein, and J. Avorn et al. Patterns of bone mineral density testing: Current guidelines, testing rates, and interventions J Gen Intern Med 19 2004 783 790
10. W.D. Leslie, and J.T. Schousboe A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world Curr Osteoporos Rep 9 2011 129 140
11. P. Alonso-Coello, A. Irfan, I. Sola, I. Gich, M. Delgado-Noguera, and D. Rigau et al. The quality of clinical practice guidelines over the last two decades: A systematic review of guideline appraisal studies Qual Saf Health Care 19 2010 e58
12. Documentos Clínicos SEMERGEN Osteoporosis 2006 Sociedad Española de Médicos de Atención Primaria Madrid
13. Osteoporosis: Manejo en Atención Primaria. Barcelona: Sociedad Española de Medicina de Familia y Comunitaria (semFYC); 2008.
14. J. González Macías, N. Guañabens Gay, C. Gómez Alonso, L. del Río Barquero, M. Muñoz Torres, and M. Delgado et al. Guías de práctica clínica en la osteoporosis posmenopáusica. Sociedad Española de Investigación Ósea y del Metabolismo Mineral Rev Clin Esp 208 Supl 1 2008 1 24
15. Guía de práctica clínica sobre osteoporosis. Madrid: Grupo de Estudio e Investigación de la Osteoporosis, Sociedad Española de Cirugía Ortopédica y Traumatología (SECOT); 2010.
16. Grupo de trabajo de la Guía de Práctica Clínica sobre Osteoporosis y Prevención de Fracturas por Fragilidad - GuíaSalud. Guía de Práctica Clínica sobre Osteoporosis y Prevención de Fracturas por Fragilidad. Plan de Calidad para el Sistema Nacional de Salud. Barcelona: Agència d'Informació, Avaluació i Qualitat en Salut (AIAQS); 2010.
17. L. Pérez Edo, A. Alonso Ruiz, D. Roig Vilaseca, A. García Vadillo, N. Guañabens Gay, and P. Peris et al. Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis Reumatol Clin 7 2011 357 379
18. National Osteoporosis Guideline Group (NOGG) on behalf of the Bone Research Society, British Geriatrics Society, British Orthopaedic Association, British Society of Rheumatology, National Osteoporosis Society, Osteoporosis 2000, Osteoporosis Dorset, Primary Care Rheumatology Society, Royal College of Physicians and Society for Endocrinology. Osteoporosis: Clinical guideline for prevention and treatment, Executive Summary. Sheffield: University of Sheffield Press; 2010.
19. National Osteoporosis Foundation (NOF) Clinician's guide to prevention and treatment of osteoporosis 2010 National Osteoporosis Foundation Washington, DC
20. N.B. Watts, J.P. Bilezikian, P.M. Camacho, S.L. Greenspan, S.T. Harris, S.F. Hodgson AACE Osteoporosis Task Force American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis Endocr Pract 16 Suppl 3 2010 1 37
21. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society Menopause 17 2010 25 54
22. A. Papaioannou, S. Morin, A.M. Cheung, S. Atkinson, J.P. Brown, and S. Feldman et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary CMAJ 182 2010 1864 1873
23. National Institute for Health and Clinical Excellence (NICE) Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended) NICE technology appraisal guidance 160 2011 National Institute for Health and Clinical Excellence London
24. National Institute for Health and Clinical Excellence (NICE) Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended) NICE technology appraisal guidance 161 2011 National Institute for Health and Clinical Excellence London
25. Grupo de trabajo de la SEIOMM Osteoporosis posmenopáusica. Guía de práctica clínica 2006 Sociedad Española de Investigaciones Óseas y Metabolismo Mineral Madrid
26. M.J. Bolland, and A. Grey Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines J Clin Endocrinol Metab 95 2010 1856 1860
27. M.G. Donaldson, P.M. Cawthon, L.Y. Lui, J.T. Schousboe, K.E. Ensrud, and B.C. Taylor et al. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines J Bone Miner Res 25 2010 1506 1511
28. S.D. Berry, D.P. Kiel, M.G. Donaldson, S.R. Cummings, J.A. Kanis, and H. Johansson et al. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: The Framingham Osteoporosis Study Osteoporos Int 21 2010 53 60
29. M.G. Donaldson, P.M. Cawthon, L.Y. Lui, J.T. Schousboe, K.E. Ensrud, and B.C. Taylor et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines J Bone Miner Res 24 2009 675 680
30. G. Sanfélix-Gimeno, J. Sanfélix-Genovés, S. Peiró, I. Hurtado, J.L. Trillo, and R. Usó et al. Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD study BMC Musculoskelet Disord 12 2011 178